Travere Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference. The company's president and CEO, Eric Dube, Ph.D., is scheduled to deliver a presentation on Tuesday, January 14, 2025, at 8:15 a.m. PT.
The presentation will be accessible through a live webcast on the Investor page of Travere's website at ir.travere.com/events-presentations. For those unable to attend live, a replay of the presentation will remain available on the website for up to 30 days after the event.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato la sua partecipazione alla prossima 43ª Conferenza Annuale J.P. Morgan Healthcare. Il presidente e CEO dell'azienda, Eric Dube, Ph.D., è programmato per fornire una presentazione martedì 14 gennaio 2025, alle 8:15 a.m. PT.
La presentazione sarà accessibile attraverso una trasmissione in diretta sul sito web per gli investitori di Travere all'indirizzo ir.travere.com/events-presentations. Per coloro che non possono partecipare dal vivo, una registrazione della presentazione sarà disponibile sul sito web fino a 30 giorni dopo l'evento.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado su participación en la próxima 43ª Conferencia Anual de J.P. Morgan Healthcare. El presidente y CEO de la compañía, Eric Dube, Ph.D., está programado para realizar una presentación el martes 14 de enero de 2025, a las 8:15 a.m. PT.
La presentación será accesible a través de una transmisión en vivo en la página de Inversores del sitio web de Travere en ir.travere.com/events-presentations. Para aquellos que no puedan asistir en vivo, una repetición de la presentación estará disponible en el sitio web durante hasta 30 días después del evento.
트래버 테라퓨틱스 (NASDAQ: TVTX)는 다가오는 제43회 JP 모건 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사의 사장 겸 CEO인 에릭 듀브, 박사는 2025년 1월 14일 화요일 오전 8:15 PT에 발표를 진행할 예정입니다.
발표는 트래버의 웹사이트 투자자 페이지 ir.travere.com/events-presentations에서 실시간 웨비나로 접근할 수 있습니다. 실시간으로 참석할 수 없는 분들은 이벤트 종료 후 30일 동안 웹사이트에서 발표를 다시 보실 수 있습니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé sa participation à la prochaine 43ème Conférence Annuelle J.P. Morgan Healthcare. Le président et PDG de l'entreprise, Eric Dube, Ph.D., doit donner une présentation le mardi 14 janvier 2025, à 8h15 PT.
La présentation sera accessible via un webinaire en direct sur la page Investisseurs du site web de Travere à l'adresse ir.travere.com/events-presentations. Pour ceux qui ne peuvent pas assister en direct, un enregistrement de la présentation sera disponible sur le site web jusqu'à 30 jours après l'événement.
Travere Therapeutics (NASDAQ: TVTX) hat seine Teilnahme an der bevorstehenden 43. J.P. Morgan Healthcare Conference bekannt gegeben. Der Präsident und CEO des Unternehmens, Eric Dube, Ph.D., wird voraussichtlich am Dienstag, den 14. Januar 2025, um 8:15 Uhr PT eine Präsentation halten.
Die Präsentation wird über einen Live-Webcast auf der Investoren-Seite von Traveres Website unter ir.travere.com/events-presentations zugänglich sein. Für diejenigen, die nicht live teilnehmen können, wird eine Wiederholung der Präsentation bis zu 30 Tage nach der Veranstaltung auf der Website verfügbar sein.
- None.
- None.
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 8:15 a.m. PT.
A live webcast of the presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and a replay will be available for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact:
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
FAQ
When is Travere Therapeutics (TVTX) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors watch Travere Therapeutics' (TVTX) J.P. Morgan Healthcare Conference presentation?
How long will the replay of TVTX's J.P. Morgan Healthcare Conference presentation be available?
Who will be presenting for Travere Therapeutics (TVTX) at the 2025 J.P. Morgan Healthcare Conference?
